Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression

Abstract Background The relationship between cancer development and alterations in IgG N-glycosylation has been well-established. However, comprehensive profiling of the N-glycome and N-glycoproteome in gastric cancer (GC) remains limited. Furthermore, the prognostic potential of IgG N-glycan patter...

Full description

Saved in:
Bibliographic Details
Main Authors: Tingting Xu, Jianmin Huang, Jiajing Lin, Yuanyuan Liu, Yi Wang, Wenkang Shen, Jianjie He, Shuyun Chen, Xi Zhu, Yuqin Que, Mengting Hu, Yu Chen, Liming Cheng, Honghao He, Xin Liu, Si Liu
Format: Article
Language:English
Published: BMC 2025-02-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-13616-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862016612237312
author Tingting Xu
Jianmin Huang
Jiajing Lin
Yuanyuan Liu
Yi Wang
Wenkang Shen
Jianjie He
Shuyun Chen
Xi Zhu
Yuqin Que
Mengting Hu
Yu Chen
Liming Cheng
Honghao He
Xin Liu
Si Liu
author_facet Tingting Xu
Jianmin Huang
Jiajing Lin
Yuanyuan Liu
Yi Wang
Wenkang Shen
Jianjie He
Shuyun Chen
Xi Zhu
Yuqin Que
Mengting Hu
Yu Chen
Liming Cheng
Honghao He
Xin Liu
Si Liu
author_sort Tingting Xu
collection DOAJ
description Abstract Background The relationship between cancer development and alterations in IgG N-glycosylation has been well-established. However, comprehensive profiling of the N-glycome and N-glycoproteome in gastric cancer (GC) remains limited. Furthermore, the prognostic potential of IgG N-glycan patterns in identifying precursors to GC has yet to be fully elucidated. Methods The IgG N-glycome in GC was characterized using a custom high-throughput orthogonal mass spectrometry approach. Multivariate analysis was employed to identify and assess glycomic alterations. A comprehensive bioinformatics analysis was also conducted to investigate the differential expression of N-glycosylation-related genes and their potential roles in GC pathogenesis. Additionally, interleukin-11 (IL-11) levels were quantified using a standardized enzyme-linked immunosorbent assay (ELISA). Results Galactosylation and sialylation of IgG decreased mainly in the IgG1 and IgG2 subclasses in GC, with subclass-specific changes in IgG3 and IgG4 galactosylation. These glycan modifications were represented by unique glycopeptides (IgG1_H5N5, IgG2_H4N3F1, IgG2_H4N4, IgG2_H4N4F1S1, IgG3/4_H4N4F1, IgG3/4_H4N4F1S1), which outperformed CA72-4 for GC diagnosis. Analysis of key glycogenes revealed differential expression patterns, implicating a functional role for IgG N-glycosylation in GC. Notably, the abundance of specific IgG glycosylation exhibited a significant correlation with serum level of IL-11. Conclusions Alterations in subclass-specific IgG N-glycosylation represent promising biomarkers for the detection and monitoring of GC progression, potentially influenced by cytokine-driven inflammation. Understanding these changes could improve our knowledge of molecular mechanisms, aiding in diagnostic improvements and therapeutic development.
format Article
id doaj-art-faf34b7b15f5491b86a159e515dc51d9
institution Kabale University
issn 1471-2407
language English
publishDate 2025-02-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-faf34b7b15f5491b86a159e515dc51d92025-02-09T12:41:35ZengBMCBMC Cancer1471-24072025-02-0125111310.1186/s12885-025-13616-zSite-specific immunoglobulin G N-glycosylation is associated with gastric cancer progressionTingting Xu0Jianmin Huang1Jiajing Lin2Yuanyuan Liu3Yi Wang4Wenkang Shen5Jianjie He6Shuyun Chen7Xi Zhu8Yuqin Que9Mengting Hu10Yu Chen11Liming Cheng12Honghao He13Xin Liu14Si Liu15Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical UniversityDigestive Endoscopy Center, Fuzhou University Affiliated Provincial HospitalThe Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and TechnologyThe Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and TechnologyDepartment of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDigestive Endoscopy Center, Fuzhou University Affiliated Provincial HospitalThe Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and TechnologyDepartment of Epidemiology and Health Statistics, School of Public Health, Fujian Medical UniversityDepartment of Epidemiology and Health Statistics, School of Public Health, Fujian Medical UniversityDepartment of Epidemiology and Health Statistics, School of Public Health, Fujian Medical UniversityDepartment of Epidemiology and Health Statistics, School of Public Health, Fujian Medical UniversityDepartment of Epidemiology and Health Statistics, School of Public Health, Fujian Medical UniversityDepartment of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologySino-US Telemed (Wuhan) Co., LtdThe Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and TechnologyDepartment of Epidemiology and Health Statistics, School of Public Health, Fujian Medical UniversityAbstract Background The relationship between cancer development and alterations in IgG N-glycosylation has been well-established. However, comprehensive profiling of the N-glycome and N-glycoproteome in gastric cancer (GC) remains limited. Furthermore, the prognostic potential of IgG N-glycan patterns in identifying precursors to GC has yet to be fully elucidated. Methods The IgG N-glycome in GC was characterized using a custom high-throughput orthogonal mass spectrometry approach. Multivariate analysis was employed to identify and assess glycomic alterations. A comprehensive bioinformatics analysis was also conducted to investigate the differential expression of N-glycosylation-related genes and their potential roles in GC pathogenesis. Additionally, interleukin-11 (IL-11) levels were quantified using a standardized enzyme-linked immunosorbent assay (ELISA). Results Galactosylation and sialylation of IgG decreased mainly in the IgG1 and IgG2 subclasses in GC, with subclass-specific changes in IgG3 and IgG4 galactosylation. These glycan modifications were represented by unique glycopeptides (IgG1_H5N5, IgG2_H4N3F1, IgG2_H4N4, IgG2_H4N4F1S1, IgG3/4_H4N4F1, IgG3/4_H4N4F1S1), which outperformed CA72-4 for GC diagnosis. Analysis of key glycogenes revealed differential expression patterns, implicating a functional role for IgG N-glycosylation in GC. Notably, the abundance of specific IgG glycosylation exhibited a significant correlation with serum level of IL-11. Conclusions Alterations in subclass-specific IgG N-glycosylation represent promising biomarkers for the detection and monitoring of GC progression, potentially influenced by cytokine-driven inflammation. Understanding these changes could improve our knowledge of molecular mechanisms, aiding in diagnostic improvements and therapeutic development.https://doi.org/10.1186/s12885-025-13616-zGastric cancerIgG N-glycansIgG glycopeptidesIL-11Bioinformatics analysis
spellingShingle Tingting Xu
Jianmin Huang
Jiajing Lin
Yuanyuan Liu
Yi Wang
Wenkang Shen
Jianjie He
Shuyun Chen
Xi Zhu
Yuqin Que
Mengting Hu
Yu Chen
Liming Cheng
Honghao He
Xin Liu
Si Liu
Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression
BMC Cancer
Gastric cancer
IgG N-glycans
IgG glycopeptides
IL-11
Bioinformatics analysis
title Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression
title_full Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression
title_fullStr Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression
title_full_unstemmed Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression
title_short Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression
title_sort site specific immunoglobulin g n glycosylation is associated with gastric cancer progression
topic Gastric cancer
IgG N-glycans
IgG glycopeptides
IL-11
Bioinformatics analysis
url https://doi.org/10.1186/s12885-025-13616-z
work_keys_str_mv AT tingtingxu sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT jianminhuang sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT jiajinglin sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT yuanyuanliu sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT yiwang sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT wenkangshen sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT jianjiehe sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT shuyunchen sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT xizhu sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT yuqinque sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT mengtinghu sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT yuchen sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT limingcheng sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT honghaohe sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT xinliu sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression
AT siliu sitespecificimmunoglobulingnglycosylationisassociatedwithgastriccancerprogression